 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Arelili® | Ariely® | HTI-1088 | HTI1088 | SHR-1316 | SHR1316
                                 adebrelimab is an approved drug (China NMPA (2023)) Compound class: 
                                                            Antibody
                                 
                                    
                                        Comment: Adebrelimab (SHR-1316; HTI-1088) is a chimeric humanized IgG4κ anti-PD-L1 monoclonal antibody.
                                    
                                 | 
| Classification  | |
| Compound class | Antibody | 
| Approved drug? | Yes. China NMPA (2023) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 11300 | adebrelimab | 
| Synonyms  | 
| Arelili® | Ariely® | HTI-1088 | HTI1088 | SHR-1316 | SHR1316 | 
| Database Links  | |
| Specialist databases | |
| IMGT/mAb-DB | 999 | 
| Other databases | |
| GtoPdb PubChem SID | 491299867 | 
| Search PubMed clinical trials | adebrelimab | 
| Search PubMed titles | adebrelimab | 
| Search PubMed titles/abstracts | adebrelimab |